Overall Survival With Addition of Relacorilant to Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer
By Matthew Stenger
Posted: 4/23/2026 10:05:00 AM
Last Updated: 4/23/2026 10:29:45 AM
As reported in The Lancet by Lorusso...
Get our latest downloads and information first.
Complete the form below to subscribe to our weekly newsletter.
